Search

Search Constraints

You searched for: Author/Creator Dy, G.

Search Results

2. 127P Phase I study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC. (December 2022)